Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMC 48648)

Published in Proc Natl Acad Sci U S A on March 15, 1992

Authors

G P Gasic1, C P Arenas, T B Gasic, G J Gasic

Author Affiliations

1: Salk Institute, La Jolla, CA 92037.

Articles citing this

The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol (1993) 2.95

Tissue factor-factor VIIa signaling. Arterioscler Thromb Vasc Biol (2004) 1.69

Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo. J Clin Invest (1997) 1.61

Biology of the TAM receptors. Cold Spring Harb Perspect Biol (2013) 1.59

Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J Clin Invest (2009) 1.47

Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. Blood (2010) 1.30

The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors. J Biol Chem (2010) 1.24

TAM receptor signaling in immune homeostasis. Annu Rev Immunol (2015) 1.18

CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol (1994) 1.09

Species-specific anticoagulant and mitogenic activities of murine protein S. Haematologica (2009) 0.96

Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway through its sex hormone-binding globulin-like region. J Neurosci (2010) 0.93

Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase. Proc Natl Acad Sci U S A (1996) 0.92

Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat. J Clin Invest (1996) 0.91

Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban. Mediators Inflamm (2011) 0.89

Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway. Mol Neurodegener (2011) 0.88

A theoretical model for the Gla-TSR-EGF-1 region of the anticoagulant cofactor protein S: from biostructural pathology to species-specific cofactor activity. J Comput Aided Mol Des (1997) 0.87

Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages. Blood (2008) 0.83

Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells. Biochem J (1995) 0.83

Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. J Clin Invest (1998) 0.81

Protease activated receptor 2 and the cardiovascular system. Br J Pharmacol (2002) 0.81

Vitamin K-dependent protein S in Leydig cells of human testis. Biochem J (1994) 0.80

A novel role for vitamin K1 in a tyrosine phosphorylation cascade during chick embryogenesis. J Clin Invest (1997) 0.79

Identification of a thrombin receptor with factor Xa receptor and tissue factor in human pancreatic carcinoma cells. Clin Mol Pathol (1995) 0.75

Articles cited by this

The pathogenesis of atherosclerosis--an update. N Engl J Med (1986) 14.59

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell (1991) 11.51

The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol (1981) 5.86

The molecular basis of blood coagulation. Cell (1988) 5.29

Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest (1988) 3.76

Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science (1990) 3.27

Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature (1987) 3.27

TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell (1990) 2.82

The regulation of natural anticoagulant pathways. Science (1987) 2.58

PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol (1990) 2.26

Developmental mechanisms underlying pathology of arteries. Physiol Rev (1990) 2.17

Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation (1989) 2.07

Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem J (1983) 1.94

Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis (1984) 1.88

Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor. J Biol Chem (1989) 1.79

Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science (1990) 1.75

The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization. J Clin Invest (1977) 1.58

Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis (1990) 1.58

Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res (1990) 1.57

Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem (1990) 1.46

Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted. J Cell Physiol (1987) 1.44

Atheroma: the artery wall and the environment. Int Rev Exp Pathol (1980) 1.30

Primary structure of bovine vitamin K-dependent protein S. Proc Natl Acad Sci U S A (1986) 1.26

Activation of coagulation releases endothelial cell mitogens. J Cell Biol (1986) 1.16

Reconstructing the evolution of vertebrate blood coagulation from a consideration of the amino acid sequences of clotting proteins. Cold Spring Harb Symp Quant Biol (1987) 1.15

Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan. J Cell Biol (1991) 1.13

Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension. Hum Pathol (1987) 1.13

Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. Arteriosclerosis (1990) 1.08

Growth inhibition by protein kinase C late in mitogenesis. Nature (1987) 1.06

Cellular interactions, growth factors, and smooth muscle proliferation in atherogenesis. Ann N Y Acad Sci (1990) 1.04

Balloon catheter de-endothelialization of the nude rat carotid. Response to injury in the absence of functional T lymphocytes. Am J Pathol (1991) 1.03

Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am J Pathol (1990) 1.01

The amino acid sequence of antistasin. A potent inhibitor of factor Xa reveals a repeated internal structure. J Biol Chem (1988) 1.00

Platelet-derived growth factor activity and mRNA expression in healing vascular grafts in baboons. Association in vivo of platelet-derived growth factor mRNA and protein with cellular proliferation. J Clin Invest (1991) 1.00

Animal models of atherosclerosis. Atherosclerosis (1990) 0.97

The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol (1991) 0.95

Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients. J Am Coll Cardiol (1991) 0.92

Smooth muscle cell proliferation in the occluded rat carotid artery: lack of requirement for luminal platelets. Am J Pathol (1979) 0.87

Sustained arterial injury and progression of atherosclerosis. Ann N Y Acad Sci (1990) 0.86

Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin. J Cell Physiol (1990) 0.85

Analysis of atherosclerosis susceptibility in mice with genetic defects in platelet function. Arteriosclerosis (1990) 0.84

Restenosis following coronary angioplasty. Am Heart J (1990) 0.82

Coronary atherosclerosis in the pig. Induced plaque injury and platelet response. Arteriosclerosis (1990) 0.81

Role of fibrinopeptide B in early atherosclerotic lesion formation. Am J Surg (1990) 0.81

A biologically plausible model of thickening of arterial intima under shear. Arteriosclerosis (1989) 0.77

Biology of the vessel wall and atherosclerosis. Clin Exp Hypertens A (1989) 0.77

Articles by these authors

Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A (1968) 2.95

Positive and negative colloidal iron as cell surface electron stains. Lab Invest (1968) 2.19

Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer (1973) 2.05

Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Rev (1984) 1.34

Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res (1987) 1.32

Antistasin, an inhibitor of coagulation and metastasis, binds to sulfatide (Gal(3-SO4) beta 1-1Cer) and has a sequence homology with other proteins that bind sulfated glycoconjugates. J Biol Chem (1989) 1.20

Anti-metastatic effect of aspirin. Lancet (1972) 1.17

Thrombogenic activity of mouse and human tumors: effects on platelets, coagulation, and fibrinolysis, and possible significance for metastases. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 1.06

Interaction of the hemostatic and immune systems in the metastatic spread of tumor cells. Int Rev Exp Pathol (1986) 1.05

The amino acid sequence of antistasin. A potent inhibitor of factor Xa reveals a repeated internal structure. J Biol Chem (1988) 1.00

Isolation and characterization of antistasin. An inhibitor of metastasis and coagulation. J Biol Chem (1987) 0.99

Aggregation of platelets and cell membrane vesiculation by rat cells transformed in vitro by Rous sarcoma virus. Cancer Res (1978) 0.87

Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles. Clin Exp Metastasis (1986) 0.84

Protease inhibitors in Haementeria leech species. Thromb Haemost (1984) 0.84

Abortifacient effects of Vibrio cholerae exo-enterotoxin and endotoxin in mice. J Reprod Fertil (1975) 0.83

Proteins and disulfide groups in the aggregation of dissociated cells of sea sponges. Science (1966) 0.82

Cloning and expression of cDNA encoding antistasin, a leech-derived protein having anti-coagulant and anti-metastatic properties. Gene (1989) 0.82

Effects of trypsin on the platelet-aggregating activity of mouse tumor cells. Thromb Res (1977) 0.81

Leech salivary gland extract from Haementeria officinalis, a potent inhibitor of cyclophosphamide- and radiation-induced artificial metastasis enhancement. Cancer Res (1984) 0.80

Cytochemical identification of protein amino acids in the cell coat of mouse ascites tumor cells. Lab Invest (1966) 0.79

Platelet aggregating material in mouse tumor cells. Removal and regeneration. Lab Invest (1977) 0.77

Inhibition of lung tumor colonization by leech salivary gland extracts from Haementeria ghilianii. Cancer Res (1983) 0.77

Plasma membrane vesicles as mediators of interactions between tumor cells and components of the hemostatic and immune systems. Prog Clin Biol Res (1982) 0.76

Total suppression of pregnancy in mice by post-coital administration of neuraminidase. Proc Natl Acad Sci U S A (1970) 0.75

Promotion of lung tumor colonization in mice by the synthetic thrombin inhibitor (no. 805) and its reversal by leech salivary gland extracts. Clin Exp Metastasis (1986) 0.75

[The effect of neuraminidase on the corpus luteum of the pregnant mouse. An ultrastructural study]. Nihon Funin Gakkai Zasshi (1975) 0.75

Comparison of basement membrane matrix degradation by purified proteases and by metastatic tumor cells. J Cell Biochem (1987) 0.75

Effect of cholera entero-exotoxin on reproductive performance in mice. Immunol Commun (1972) 0.75